明尼阿波利斯 - 临床阶段生物制药公司DiaMedica Therapeutics Inc. (NASDAQ: DMAC )宣布，Daniel J. O'Connor已于上周一正式加入其董事会。O'Connor在生物制药行业拥有丰富经验，曾在Ambrx Biopharma, Inc.、ImClone Systems、Bracco Diagnostics和现为Syneos ...

报告盘点的辐射剂量管理行业内重点企业有Novarad Corporation, Bayer AG, Siemens Healthineers, Fujifilm Holdings Corporation, AGFA Healthcare, GE Healthcare, PACSHealth LLC, Bracco Imaging S.p.A., McKesson Corporation, ...